Biblio

Schwarz AM, Seekins CA, El-Sissi O, Streicher JM.  2025.  Terpene blends from Cannabis sativa are cannabimimetic and antinociceptive in a mouse chronic neuropathic pain model via activation of adenosine A receptors.. Neurosci Lett. 854:138205.

Schwarz AM, Kobeci D, Mancuso JA, Moreno-Rodríguez V, Seekins C, Bui T, Welborn A, Carr J, Streicher JM.  2024.  Select Minor Cannabinoids from Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain.. J Pharmacol Exp Ther. 391(2):214-221.

LaVigne JE, Hecksel R, Keresztes A, Streicher JM.  2021.  Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity.. Sci Rep. 11(1):8232.

Johnston B, Vanderah TW.  2020.  Lost in the Haze: The Physician's Role in Cannabinoid Prescribing and Advising.. Am J Med. 133(1):7-8.

Ellingson HM, Vanderah TW.  2020.  Potential therapeutic treatments of cancer-induced bone pain.. Curr Opin Support Palliat Care. 14(2):107-111.

Keresztes A, Streicher JM.  2017.  Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies? FEBS Lett. 591(20):3235-3251.

Lozano-Ondoua AN, Hanlon KE, Symons-Liguori AM, Largent-Milnes TM, Havelin JJ, Ferland HL, Chandramouli A, Owusu-Ankomah M, Nikolich-Zugich T, Bloom AP et al..  2013.  Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.. J Bone Miner Res. 28(1):92-107.

Tumati S, Largent-Milnes TM, Keresztes A, Ren J, Roeske WR, Vanderah TW, Varga EV.  2012.  Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist.. J Neuroimmunol. 244(1-2):23-31.

Lozano-Ondoua AN, Wright C, Vardanyan A, King T, Largent-Milnes TM, Nelson M, Jimenez-Andrade JMiguel, Mantyh PW, Vanderah TW.  2010.  A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss.. Life Sci. 86(17-18):646-53.